Precision Optics Corporation, Inc. (POCI)

In the past six months, POCI's stock has been impacted by several events, including reporting record Q1 FY2026 revenue but a net loss, new product development agreements for augmented reality sub-systems and custom borescopes, and an initial production order for a new ophthalmic endoscope. The company also reported Q4 and Fiscal Year 2025 financial results, participated in investor conferences, and saw insider buying activity. The stock's 52-week trading range has been between $3.77 and $6.04.

Demand for Precision Optics' products and services appears relatively stable, driven by the number of procedures for single-use medical products and consistent demand for high-performance optical assemblies in the defense sector. The company benefits from a strong backlog of production programs, providing good visibility into future demand.

Precision Optics Corp., Inc. specializes in advanced optical and illumination systems, operating in the Healthcare sector, specifically the Medical Instruments & Supplies industry. The company's products include medical instrumentation like endoscopes and micro medical cameras, as well as components for industrial and military applications.

Precision Optics Corp., Inc. primarily operates and generates revenue within the United States. The company has headquarters in Gardner and Littleton, Massachusetts.

Precision Optics maintains a positive standing within its target markets, as evidenced by overwhelmingly positive customer and surgeon feedback on their new CMOS-based flexible endoscopes. The company's ability to secure new development and production orders in the medical and defense/aerospace sectors indicates a strong reputation and trust from its clientele.

Precision Optics Corp., Inc. has 30 institutional owners and shareholders, holding 13.71% of the company's stock. Major institutional owners include Needham Investment Management Llc, WealthTrust Axiom LLC, and Vanguard Group Inc. The company's CEO, Joe Forkey, directly owns 1.85% of the company's shares.